Treatment of Beta-Lactam Resistant Staphylococcus aureus Respiratory Infection

Empiric Treatment Selection

• The Infectious Diseases Society of America recommends vancomycin 15 mg/kg IV every 8-12 hours or linezolid 600 mg IV every 12 hours as first-line agents for S. aureus respiratory infections with beta-lactam resistance 1, 2
• For severe illness, a loading dose of 25-30 mg/kg IV × 1 of vancomycin should be considered 1

Critical Distinction: Beta-Lactamase vs Methicillin Resistance

• The American College of Physicians recommends using beta-lactamase-resistant penicillins or first-generation cephalosporins for beta-lactamase-positive but methicillin-susceptible S. aureus (MSSA) 3, 1
• Vancomycin should not be used for MSSA due to higher failure rates and slower bacteremia clearance compared to nafcillin or oxacillin 3, 4

Treatment Duration

• The Infectious Diseases Society of America recommends 7-14 days of therapy for S. aureus respiratory infections, individualized based on clinical response 2
• Clinical response should be assessed within 48-72 hours of initiating therapy 2

Alternative Agents for Special Circumstances

• For non-anaphylactic penicillin allergy, first-generation cephalosporins can be used safely in approximately 90% of patients 3, 4
• For severe penicillin allergy, vancomycin is the appropriate alternative 3, 4

Monitoring

• Follow-up cultures should be obtained 48-72 hours after initiating therapy 2
• Vancomycin trough levels should be monitored before the 4th dose to ensure therapeutic range of 15-20 mg/mL 1